Optic Nerve Disorders Treatment Market is expected to reach USD 2.73 billion by 2029

In recent years, the optic nerve disorders treatment market is anticipated to grow rapidly during the forecast period. The retina and optic nerve are among the critical elements of the eye. The retina collects the image, and the captured image is transmitted to the brain for analysis. Trauma, multiple sclerosis (M.S.), and glaucoma affect the optic nerve. As per the World Health Organization (WHO), 2.2 billion individuals were affected by vision impairment or blindness in 2019. Cataracts, uncorrected refractive errors, corneal opacification, glaucoma, and other conditions are among the most common causes of vision impairment.

Data Bridge Market Research analyses that the optic nerve disorders treatment market was valued at USD 1.92 billion in 2021 and is expected to reach USD 2.73 billion by 2029, registering a CAGR of 4.50% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

The second cranial nerve, the optic nerve of the eye, assists in the transmission of sensory information to the brain for vision. During fetal development, the optic vesicle of the forebrain develops into this nerve. Loss of vision can occur if the optic nerve or its routes to the brain are damaged. Glaucoma, optic nerve atrophy, optic neuritis, and optic nerve head drusen are all common optic nerve illnesses found throughout the world. The majority of these illnesses are treated symptomatically. The treatments may not enhance eyesight, but they can help prevent visual loss as the illness progresses.

View Detailed Report@ https://www.databridgemarketresearch.com/reports/global-optic-nerve-disorders-treatment-market

Drivers

Increasing prevalence of eye diseases
The rising prevalence of eye diseases is estimated to enhance the growth of the optic nerve disorders treatment market. As per the American Academy of Ophthalmology, approximately 7.32 million people will be diagnosed with primary open-angle glaucoma (POAG) in 2019, with the highest rates among people aged 70 to 79 years old (32%), women (50%), and Hispanics (50 percent ).

Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of optic nerve disorders treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Rising number of cases of glaucoma
The surging number of glaucoma and multiple sclerosis (M.S.) cases is anticipated to expand the optic nerve disorders treatment market. Glaucoma is referred to a medical condition which is characterized by a rise in intraocular fluid pressure. The inflammation of the optic nerve causes optic neuritis, while other illnesses are triggered by physical injury to the optic nerve or the development of protein or calcium pockets in the optic nerve.

Some of the major players operating in the optic nerve disorders treatment market are:

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (France)
Pfizer Inc. (U.S.)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
Zydus Cadila (India)
Boehringer Ingelheim International GmbH. (Germany)
Apotex Inc. (Canada)
AstraZeneca (U.K.)
Johnson & Johnson (U.S.)
Bayer AG (Germany)
Sun Pharmaceutical Industries Ltd. (India)
LEO Pharma A/S (Denmark)
Bausch Health Companies Inc. (Canada)
Allergan (Ireland)
Eli Lilly and Company (U.S.)
Aurobindo Pharma (India)
Lupin (India)

Browse More reports:

https://dbmrbuisness.blogspot.com/2023/09/global-uterotonic-agent-market-industry.html

https://www.blogger.com/blog/post/preview/2488328241346209773/1259491110386480580

https://dbmrbuisness.blogspot.com/2023/09/global-antidotes-market-industry-trends.html

https://dbmrbuisness.blogspot.com/2023/09/global-cephalosporin-market-industry.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.